Catalog ID
PTL-TIRZ
Tirzepatide
Dual GIP/GLP-1 receptor agonist; weight-management research peptide
Tirzepatide, a dual GIP and GLP-1 receptor agonist, investigated in appetite signaling, energy-intake regulation and weight-management research models.
Molecular Formula
C225H348N56O88
Formula as supplied.
Purity
≥98%
Molecular Weight
4813.5 g/mol (reported)
Classification
Dual GIP/GLP-1 receptor agonist
Price
$1.00 – $320.00 USD
Indicative range · converted from USD · free shipping from €500
Pricing tiers · mass & purity
1 mg
$320.00
≥98%
5 mg
$1.00
≥98%
10 mg
$1.00
≥98%
Scientific Background
Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It is studied in weight-management and metabolic research for effects on appetite regulation, energy intake and glucose-dependent insulin secretion in preclinical and clinical models.
Research Focus — Pathways
GIP and GLP-1 receptor signaling; cAMP-mediated insulin secretion; appetite/energy regulation.
Research Areas
- GIP receptor agonism
- GLP-1 receptor agonism
- Appetite signaling
- Energy balance
- Adiposity research
Molecular Formula
C225H348N56O88
Formula as supplied.
Molecular Weight
4813.5 g/mol (reported)
Amino Acid Sequence
YAibEGTFTSDVSSYLEGQAAKEFIAWLVRGT (modified, dual agonist)
Classification
Dual GIP/GLP-1 receptor agonist
Research Format
Lyophilized research reagent
Purity
≥98%
Peptide Classification
Dual GIP/GLP-1 receptor agonist
Sequence Notation
YAibEGTFTSDVSSYLEGQAAKEFIAWLVRGT (modified, dual agonist)
Scientific References
The following authoritative sources provide peer-reviewed literature on Tirzepatide. Peptide Hub Biotech World Wide does not claim these sources endorse this product.
Tirzepatide — PubChem compound data
PubChem
https://pubchem.ncbi.nlm.nih.gov/#query=TirzepatideGIP precursor — UniProt sequence & function
UniProt
https://www.uniprot.org/search?query=gastric%20inhibitory%20polypeptideTirzepatide — PubMed literature
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=tirzepatide
Tirzepatide — frequently asked
What is Tirzepatide used for in research?
Tirzepatide (Dual GIP/GLP-1 receptor agonist; weight-management research peptide) is investigated in gip receptor agonism, glp-1 receptor agonism, appetite signaling, energy balance, adiposity research research. Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It is studied in weight-management and metabolic research for effects on appetite regulation, energy intake and glucose-dependent insulin secretion in preclinical and clinical models.
What purity and documentation does Tirzepatide include?
Tirzepatide is supplied at ≥98% reported purity as a Lyophilized research reagent. A Certificate of Analysis (COA) is available on request with every order.
Does Peptide Hub Biotech World Wide ship Tirzepatide to the USA, Canada, Europe, Australia and New Zealand?
Yes. Peptide Hub Biotech World Wide ships Tirzepatide to research customers in the United States, Canada, across Europe, Australia, New Zealand and South American markets. Bulk and wholesale quotes are available via the contact form.
How can I order Tirzepatide?
Order directly from each product page via our Bitcoin (BTC) checkout — there is no minimum order, and shipping is free on orders from €500 (converted to your local currency). For bulk or wholesale quantities, request a quote through the contact form. After payment, confirm your transaction by email and shipping will proceed.
Related Products
NEWWeight Management≥98%Semaglutide
GLP-1 receptor agonist studied in appetite regulation, energy intake and adiposity research.
NEWWeight Management≥98%Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist studied in adiposity and energy-balance research.
Metabolic & Endocrine99.2%GLP-1 Receptor Agonists
Glucagon-like peptide-1 receptor agonists studied in metabolic and glucose-regulation research.
QC & Quality Systems
Every lot is verified by HPLC and mass-spectrometry purity analysis, peptide-content determination and residual-solvent testing, with a Certificate of Analysis issued per batch — aligned to ISO 9001:2015 and ISO 13485:2016 quality systems, with FDA Drug Master File (DMF) and MDSAP regulatory pathways supported.
ISO 9001:2015
Quality Management System
ISO 13485:2016
Medical Device QMS
FDA DMF
Drug Master File
MDSAP
Medical Device Single Audit Program
Quality & Documentation
Certificate of Analysis available on request · Research Use Only
Request a Quote